Our top coverage from this year’s Community Oncology Conference, hosted by the Community Oncology Alliance, included discussions around alternative payment models, shifts in the community oncology landscape in recent decades, and the need for reform in several areas.
Our top coverage from this year’s Community Oncology Conference, hosted by the Community Oncology Alliance (COA), included discussions around alternative payment models, shifts in the community oncology landscape in recent decades, and the need for reform in several areas, including pharmacy benefit manager (PBM) practices, 340B drug discounts, and the Inflation Reduction Act (IRA).
5. Ben Jones: Collaboration Between CMMI, Providers, Practices Needed for EOM
Ben Jones, vice president of Government Relations and Public Policy at the US Oncology Network, discussed a range of issues raised at the 2023 Community Oncology Conference in an interview with The American Journal of Managed Care® (AJMC®). While many themes took shape at this year’s meeting, including discussions around the cost of care and the potential for value-based approaches, Jones highlighted conversations around PBMs and the Enhancing Oncology Model (EOM) as crucial topics in community oncology.
4. Dr Debra Patt: Consolidation and New Advanced Therapies in Oncology
In an interview with AJMC, Debra Patt, MD, PhD, MBA, executive vice president at Texas Oncology, discussed changes that community oncology has gone through in recent decades, including consolidation of practices driven by market shifts aligning with large hospital systems. Patt also gave insight into the remarkable strides in cancer therapeutics in the same time frame, such as immunotherapies and targeted therapies.
3. As Decision Time on EOM Nears, Lots of Questions From COA Panel
Payment reform has been a hot topic in the oncology space in recent years, but a panel at the 2023 COA Community Oncology Conference raised a number of concerns around the EOM, an alternative payment model that the Center for Medicare and Medicaid Innovation launched in July of 2023. While many attendees at the meeting had hoped to say “yes” to the EOM—which hadn’t yet begun at the time—many of the model’s parameters, including practices taking on downside risk from the start, elicited frustration from panelists.
2. COA: An Advocacy Group Born in Crisis Looks Back at 20 Years
COA marked its 20th year at the annual Community Oncology Conference, and the opening session of the meeting welcomed back former presidents and highlighted the early days of the group’s work on Capitol Hill. While policies have changed and the group’s impact has grown in the 20 years since its inception, it retains the spirit of an upstart advocacy group in many ways, its leaders said. A panel discussion on the value of community oncology rounded out the session.
1. Could This Be the Year for PBM Reform? COA Panel Weighs in
A group of Capitol Hill experts took part in discussions around PBMs, the IRA, and 340B reform, highlighting areas that have finally become topics of “mainstream conversation” thanks in part to COA’s efforts. While COA leaders have long been working to raise awareness of alarming practices by PBMs, bipartisan awareness of said practices has only recently come to a point at which Congress might act, according to the panelists. The discussion also highlighted potential impacts of the IRA on providers, as well as the need to ensure that 340B drug discounts are pulled through to patients.
Bringing Connectivity to the Specialty Pharmacy Workflow
May 2nd 2024In a session during the final full day of conference activity at AXS24, experts from CVS Health and Surescripts emphasized the need to simplify the prescribing workflow for specialty medication through proactive messaging, automation, and interoperability.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More